Insulin resistance is a risk factor for progression to Type 1 diabetes

Diabetologia

Volumn 47, Issue 10, 2004, Pages 1661-1667

  Fourlanos, S ^a   Narendran, P ^a,b   Byrnes, G B ^c   Colman, P G ^d   Harrison, L C ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

First phase insulin response; HOMA R; Insulin resistance; Islet autoantibody; Prediction; Type 1 diabetes

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REDUCTION; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; GLUCOSE; HLA-DR ANTIGENS; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; RISK FACTORS;

EID: 11144298970     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1507-3     Document Type: Article

References (38)

1. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA (1997) Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46:1701-1710
2. Verge CF, Stenger D, Bonifacio E et al. (1998) Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47:1857-1866
3. Harrison LC (2001) Risk assessment, prediction and prevention of type 1 diabetes. Pediatr Diabetes 2:71-82
4. Bingley PJ, Bonifacio E, Ziegler AG, Schatz DA, Atkinson MA, Eisenbarth GS (2001) Proposed guidelines on screening for risk of type 1 diabetes. Diabetes Care 24:398
5. Kahn SE, Prigeon RL, McCulloch DK et al. (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672
6. Yki-Jarvinen H, Koivisto VA (1986) Natural course of insulin resistance in type I diabetes. N Engl J Med 315:224-230
7. Smith CP, Archibald HR, Thomas JM et al. (1988) Basal and stimulated insulin levels rise with advancing puberty. Clin Endocrinol (Oxf) 28:7-14
8. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EA (1991) Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 165:1667-1672
9. Greenbaum CJ (2002) Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev 18:192-200
10. Buschard K, Buch I, Mølsted-Pedersen L, Hougaard P, Kühl C (1987) Increased incidence of true type 1 diabetes acquired during pregnancy. BMJ 294:275-279
11. McCulloch DK, Klaff LJ, Kahn SE et al. (1990) Non-progression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes 39:549-556
12. Amrani A, Durant S, Throsby M, Coulaud J, Dardenne M, Homo-Delarche F (1998) Glucose homeostasis in the nonobese diabetic mouse at the prediabetic stage. Endocrinology 139:1115-1124
13. Beales PE, Pozzilli P (2002) Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev 18:114-117
14. Colman PG, McNair P, Margetts H et al. (1998) The Melbourne Pre-Diabetes Study: prediction of type 1 diabetes mellitus using antibody and metabolic testing. Med J Aust 169:81-84
15. American Diabetes Association (2002) Clinical Practice Recommendations 2002. Diabetes Care 25 [Suppl 1]:S1-S147
16. Vardi P, Dib SA, Tuttleman M et al. (1987) Competitive insulin autoantibody assay. Prospective evaluation of sub-jects at high risk for development of type I diabetes mellitus. Diabetes 36:1286-1291
17. Petersen JS, Hejnaes KR, Moody A et al. (1994) Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459-467
18. Bingley PJ, Colman P, Eisenbarth GS et al. (1992) Standardization of IVGTT to predict IDDM. Diabetes Care 15:1313-1316
19. McNair PD, Colman PG, Alford FP, Harrison LC (1995) Reproducibility of the first-phase insulin response to intravenous glucose is not improved by retrograde cannulation and arterialization or the use of a lower glucose dose. Diabetes Care 18:1168-1173
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
21. Haffner SM, Miettinen H, Stern MP (1997) The homeostasis model in the San Antonio Heart Study. Diabetes Care 20:1087-1092
22. Radziuk J (2000) Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 85:4426-4433
23. Bonora E, Targher G, Alberiche M et al. (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63
24. Hermans MP, Levy JC, Morris RJ, Turner RC (1999) Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42:678-687
25. Katsuki A, Sumida Y, Gabazza EC et al. (2001) Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 24:362-365
26. Emoto M, Nishizawa Y, Maekawa K et al. (1999) Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22:818-822
27. Wallace TM, Matthews DR (2002) The assessment of insulin resistance in man. Diabet Med 19:527-534
28. Bruining GJ (2000) Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes. Lancet 356:655-656
29. McCarthy HD, Ellis SM, Cole TJ (2003) Central overweight and obesity in British youth aged 11-16 years: cross sectional surveys of waist circumference. BMJ 326:624
30. Campbell IL, Harrison LC (1990) A new view of the beta cell as an antigen-presenting cell and immunogenic target. J Autoimmun 3:53-62
31. Katsuki A, Sumida Y, Murashima S et al. (1998) Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:859-862
32. Hak AE, Pols HA, Stehouwer CD et al. (2001) Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab 86:4398-4405
33. Harrison LC, Flier JS, Roth J, Karlsson FA, Kahn CR (1979) Immunoprecipitation of the insulin receptor: a sensitive assay for receptor antibodies and a specific technique for receptor purification. J Clin Endocrinol Metab 48:59-65
34. Maedler K, Sergeev P, Ris F et al. (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860
35. Maedler K, Spinas GA, Lehmann R et al. (2001) Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 50:1683-1690
36. Aaen K, Rygaard J, Josefsen K et al. (1990) Dependence of antigen expression on functional state of beta-cells. Diabetes 39:697-701
37. Bjork E, Kampe O, Karlsson FA et al. (1992) Glucose regulation of the autoantigen GAD65 in human pancreatic islets. J Clin Endocrinol Metab 75:1574-1576
38. Donath MY, Gross DJ, Cerasi E, Kaiser N (1999) Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738-744